ArticleDiabetologia2025

Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.

Aikaterini Eleftheriadou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.